Antimicrobial Resistance: Threat, consequences and options

  10 April 2019

Antimicrobial therapy is the mainstay of the three biggest public health programmes— HIV, tuberculosis and malaria. In tuberculosis and malaria, drug resistance has already emerged as a critical issue that is seriously threatening to undo the achievements made by the global community, even after investments of billions of dollars of national and international resources.

Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed